Deutsche Bank Raises Price Target on Acadia Healthcare to $46 From $32, Keeps Buy Rating
Deutsche Bank has increased its price target for Acadia Healthcare Company, Inc. from $32 to $46 while maintaining a Buy rating.
Stocks · News reference
Acadia Healthcare, led by CEO Catherine Owen Adams, has announced its support for the Raregivers Coalition's public service announcement campaign to raise awareness for the challenges faced by caregivers.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Deutsche Bank has increased its price target for Acadia Healthcare Company, Inc. from $32 to $46 while maintaining a Buy rating.
Guggenheim has increased its price target for Acadia Healthcare to $41 from $39.
UBS has raised its price target for Acadia Healthcare Company, Inc. to $45 from $41 and continues to maintain a Buy rating.
RBC Capital Markets has increased its price target for Acadia Healthcare Company, Inc. to $41 from $31 while maintaining an Outperform rating.